ITE is an AhR agonist with Ki value of 3nM, and also inhibits TGF-β-induced human myofibroblast differentiation.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | AhR ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
StemRegenin 1 |
++
Aryl hydrocarbon receptor (AhR), IC50: 127 nM |
99%+ | |||||||||||||||||
CH-223191 |
+++
AhR, IC50: 30 nM |
99%+ | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | The aryl hydrocarbon receptor (AHR) is a ligand-inducible transcription factor that is best known because it mediates the actions of polycyclic and halogenated aromatic hydrocarbon environmental toxicants such as 3-methylcholanthrene and 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. ITE is a ligand that binds directly to the AHR to induce receptor activity with Ki of 3 nM [3]. Treatment with ITE inhibited the cellular immune responses against the uveitogenic antigen, interphotoreceptor retinoid-binding protein (IRBP), and the CFA component, PPD, as measured in vitro. Treatment with ITE by daily intraperitoneal injection of 0.2 mg efficiently inhibited the development of EAU in B10.A mice induced by immunization with IRBP of 40 μg. Further learning about the effect of ITE treatment on the immune system showed that the proportions of cells expressing IFN-γ or IL-17 were lower in the ITE-treated mice than in their controls [4]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00386100 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | - |
NCT01243424 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT03108768 | Hearing Loss, Bilateral Sensor... 展开 >>ineural, Progressive 收起 << | Not Applicable | Completed | - | Switzerland ... 展开 >> Sonova AG Stafa, Zürich, Switzerland, 8712 收起 << |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.49mL 0.70mL 0.35mL |
17.46mL 3.49mL 1.75mL |
34.93mL 6.99mL 3.49mL |
CAS号 | 448906-42-1 |
分子式 | C14H10N2O3S |
分子量 | 286.306 |
别名 | |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Inert atmosphere,2-8°C |
溶解度 |
DMSO: 40 mg/mL(139.71 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |